Ranbaxy Rank

Rediff.com » News » Ranbaxy Rank

News for Ranbaxy Rank

Business

Indian company best fit for Merck Generics

The Indian company that acquires Merck Generics, the multinational drug maker's generics (non-patented) business, up for sale, will be able to compete against the top global players -- Teva, Ivax......

Sun Pharma to delist Ranbaxy on completion of $4-bn merger

Sun Pharmaceutical on Wednesday said Ranbaxy will be delisted from the Indian bourses following the completion of their $4-billion merger. "Following the closure of this transaction, Ranbaxy will......

Lessons from the Fortis/Raymond family feuds

'Nothing in this world is permanent. So also in business.''And more so in family businesses where family issues often influence business decisions,' point out S Subramanian and Nupur Pavan Bang.......

As shares plunge to 5-year low, Sun Pharma promoters poorer by Rs 12,660 crore in 10 days

Sun Pharma’s market capitalisation stood at Rs 100,050 crore on December 5, with its share price closing at Rs 417 a piece - lowest since March 2013. The country’s leading drug maker......

Ranbaxy hires BCG, Mercer for internal strategic project

Consultants are working with various teams on manufacturing, R&D, etc, to assess per-month productivity of each departmentRanbaxy Laboratories has hired the Boston Consulting Group (BCG) and Mercer......

Rediff News

Ranbaxy Rank

News for Ranbaxy Rank

Indian company best fit for Merck Generics

Sun Pharma to delist Ranbaxy on completion of $4-bn merger

Lessons from the Fortis/Raymond family feuds

As shares plunge to 5-year low, Sun Pharma promoters poorer by Rs 12,660 crore in 10 days

Ranbaxy hires BCG, Mercer for internal strategic project

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS